professionalr
☆    

India,
2025-01-31 00:00
(13 d 10:03 ago)

Posting: # 24353
Views: 296
 

 Bioequivalence studies for GCC submission [Design Issues]

Hi friends,
Would it be acceptable to conduct bioequivalence studies for GCC submission at CRO if the facility has already been inspected by the US FDA? We don’t have separate GCC facility approval.

Thanks,
RP.
drgunasakaran1
★★  
avatar

2025-01-31 04:20
(13 d 05:42 ago)

@ professionalr
Posting: # 24354
Views: 255
 

 Bioequivalence studies for GCC submission

❝ Would it be acceptable to conduct bioequivalence studies for GCC submission at CRO if the facility has already been inspected by the US FDA? We don’t have separate GCC facility approval.

If the CRO has been approved in the last two years by two of the following drug regulatory agencies such as US FDA, Health Canada, TGA - Australia, UK MHRA, EMA, or WHO, along with one additional authority from the list, then you can include CRO name in the list of bioequivalence centers approved by GCC and you can conduct studies for GCC submission.

Dr Gunasakaran Sambandan MD
Disclaimer: The replies/posts are my personal opinions, and they do not represent my company's views on the same. LinkedIn
UA Flag
Activity
 Admin contact
23,380 posts in 4,914 threads, 1,661 registered users;
36 visitors (0 registered, 36 guests [including 4 identified bots]).
Forum time: 10:03 CET (Europe/Vienna)

Everything is trivial, if you know the answer.    Thomas Jaki

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5